Global Antiretroviral Therapy Market, By Class (Nucleoside Reverse Transcriptase Inhibitors, HIV Protease Inhibitors, Non-nucleoside Reverse Transcriptase Inhibitors, Nucleotide Reverse Transcriptase Inhibitors, HIV Fusion Inhibitors, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Antiretroviral Therapy Market
Antiretroviral therapy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of HIV infection worldwide and emerging markets are the factors responsible for the growth of this market.
Growing cases of sexually transmitted diseases drive the antiretroviral therapy market. Due to increased sexually transmitted diseases, use of infected syringes & blood products and family history with the HIV infection also boost up the antiretroviral therapy market growth. Moreover, the easy availability of diagnosis tests treatments and patient’s awareness regarding diseases and treatment will boost up the global antiretroviral therapy market. However, stringent FDA guidelines for approval and commercialization of new drugs are expected to hamper the global antiretroviral therapy market.
Antiretroviral drugs are the medical agents used to treat human immunodeficiency virus infection. These agents do not kill or cure the virus; however, they can prevent the growth of the virus. HIV is a type of virus called retrovirus and a combination of drugs used to treat the infection called antiretroviral therapy.
This antiretroviral therapy market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Antiretroviral Therapy Market Scope and Market Size
The antiretroviral therapy market is segmented on the basis of class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of class, the antiretroviral therapy market is segmented into nucleoside reverse transcriptase inhibitors, HIV protease inhibitors, non-nucleoside reverse transcriptase inhibitors, nucleotide reverse transcriptase inhibitors, HIV fusion inhibitors and others.
- Route of administration segment of antiretroviral therapy market is segmented into oral, parenteral and others.
- On the basis of end-users, the antiretroviral therapy market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the antiretroviral therapy market has also been segmented into hospital pharmacy, retail pharmacy others.
Antiretroviral Therapy Market Country Level Analysis
Global antiretroviral therapy is analysed and market size information is provided by country, class, treatment, route of administration, end-users and distribution channel as referenced above.
The countries covered in the antiretroviral therapy market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America dominates the market share due to the presence of key manufacture of the product, high research and development and healthcare expenditure and skilled professionals. Europe is anticipated to be second largest market for antiretroviral therapy due to increased incidence of HIV infection. Asia-Pacific is expected to account for the largest market share over coming years for the antiretroviral therapy market due to increased awareness and number of generic drugs.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global antiretroviral therapy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Antiretroviral Therapy Market Share Analysis
Global antiretroviral therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to antiretroviral therapy market.
The major players covered in the antiretroviral therapy market are Teva Pharmaceutical Industries Ltd., Lupin, ViiV Healthcare, Bristol-Myers Squibb Company, Mylan N.V., Sun Pharmaceutical Industries Ltd., Abbvie Inc., Boehringer Ingelheim International GmbH, Novartis AG, Allergan, Merck & Co., Inc., Sanofi, and Gilead Sciences Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.